{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:55:42Z","timestamp":1790729742677,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00522643"],"award-info":[{"award-number":["RS-2025-00522643"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10120-025-01673-z","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T08:59:08Z","timestamp":1759222748000},"page":"1046-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Type 2 diabetes in patients undergoing gastric cancer surgery: areas requiring disease-specific glycemic management"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6836-744X","authenticated-orcid":false,"given":"Jimin","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1779-8683","authenticated-orcid":false,"given":"Sungsoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4432-7403","authenticated-orcid":false,"given":"Yeongkeun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"1673_CR1","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, et al. Global cancer observatory: cancer today Lyon: Intern Agency Res on Cancer. 2020 [cited 2025 May 29]. https:\/\/gco.iarc.fr\/today\/en."},{"key":"1673_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/jamasurg.2023.0096","volume":"158","author":"T Etoh","year":"2023","unstructured":"Etoh T, Ohyama T, Sakuramoto S, Tsuji T, Lee SW, Yoshida K, et al. Five-year survival outcomes of laparoscopy-assisted vs open distal gastrectomy for advanced gastric cancer: the JLSSG0901 randomized clinical trial. JAMA Surg. 2023;158:445\u201354. https:\/\/doi.org\/10.1001\/jamasurg.2023.0096.","journal-title":"JAMA Surg"},{"key":"1673_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1055\/s-0034-1391284","volume":"47","author":"YI Kim","year":"2015","unstructured":"Kim YI, Kim YW, Choi IJ, Kim CG, Lee JY, Cho SJ, et al. Long-term survival after endoscopic resection versus surgery in early gastric cancers. Endoscopy. 2015;47:293\u2013301. https:\/\/doi.org\/10.1055\/s-0034-1391284.","journal-title":"Endoscopy"},{"key":"1673_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3748\/wjg.v21.i4.1173","volume":"21","author":"EK Lee","year":"2015","unstructured":"Lee EK, Kim SY, Lee YJ, Kwak MH, Kim HJ, Choi IJ, et al. Improvement of diabetes and hypertension after gastrectomy: a nationwide cohort study. World J Gastroenterol. 2015;21:1173\u201381. https:\/\/doi.org\/10.3748\/wjg.v21.i4.1173.","journal-title":"World J Gastroenterol"},{"key":"1673_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.21147\/j.issn.1000-9604.2020.05.08","volume":"32","author":"X Chen","year":"2020","unstructured":"Chen X, Chen Y, Li T, Jun L, Lin T, Hu Y, et al. Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy. Chin J Cancer Res. 2020;32:631\u201344. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2020.05.08.","journal-title":"Chin J Cancer Res"},{"key":"1673_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111435","volume":"124","author":"A Chatterjee","year":"2024","unstructured":"Chatterjee A, Roy T, Swarnakar S. Transcriptional upregulation of MMP-9 gene under hyperglycemic conditions in AGS cells: Role of AP-1 transcription factor. Cell Signal. 2024;124:111435. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111435.","journal-title":"Cell Signal"},{"key":"1673_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/jco.2003.07.125","volume":"21","author":"JA Meyerhardt","year":"2003","unstructured":"Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003;21:433\u201340. https:\/\/doi.org\/10.1200\/jco.2003.07.125.","journal-title":"J Clin Oncol"},{"key":"1673_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2337\/dc11-1313","volume":"35","author":"CJ Currie","year":"2012","unstructured":"Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, Morgan CL. Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care. 2012;35:299\u2013304. https:\/\/doi.org\/10.2337\/dc11-1313.","journal-title":"Diabetes Care"},{"key":"1673_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/sla.0000000000001086","volume":"263","author":"CK Lee","year":"2016","unstructured":"Lee CK, Jung M, Jung I, Heo SJ, Jeong YH, An JY, et al. Cumulative metformin use and its impact on survival in gastric cancer patients after gastrectomy. Ann Surg. 2016;263:96\u2013102. https:\/\/doi.org\/10.1097\/sla.0000000000001086.","journal-title":"Ann Surg"},{"key":"1673_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10120-021-01216-2","volume":"25","author":"Y Kwon","year":"2022","unstructured":"Kwon Y, Kwon JW, Ha J, Kim D, Cho J, Jeon SM, et al. Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score. Gastric Cancer. 2022;25:265\u201374. https:\/\/doi.org\/10.1007\/s10120-021-01216-2.","journal-title":"Gastric Cancer"},{"key":"1673_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/sla.0000000000001445","volume":"262","author":"HM Heneghan","year":"2015","unstructured":"Heneghan HM, Zaborowski A, Fanning M, McHugh A, Doyle S, Moore J, et al. Prospective study of malabsorption and malnutrition after esophageal and gastric cancer surgery. Ann Surg. 2015;262:803\u20138. https:\/\/doi.org\/10.1097\/sla.0000000000001445.","journal-title":"Ann Surg"},{"key":"1673_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10120-019-01036-5","volume":"23","author":"T Kubota","year":"2020","unstructured":"Kubota T, Shoda K, Ushigome E, Kosuga T, Konishi H, Shiozaki A, et al. Utility of continuous glucose monitoring following gastrectomy. Gastric Cancer. 2020;23:699\u2013706. https:\/\/doi.org\/10.1007\/s10120-019-01036-5.","journal-title":"Gastric Cancer"},{"key":"1673_CR13","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1245\/s10434-015-5065-3","volume":"23","author":"JL Davis","year":"2016","unstructured":"Davis JL, Selby LV, Chou JF, Schattner M, Ilson DH, Capanu M, et al. Patterns and predictors of weight loss after gastrectomy for cancer. Ann Surg Oncol. 2016;23:1639\u201345. https:\/\/doi.org\/10.1245\/s10434-015-5065-3.","journal-title":"Ann Surg Oncol"},{"key":"1673_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13679-022-00470-4","volume":"11","author":"A Fogarasi","year":"2022","unstructured":"Fogarasi A, Gonzalez K, Dalamaga M, Magkos F. The impact of the rate of weight loss on body composition and metabolism. Curr Obes Rep. 2022;11:33\u201344. https:\/\/doi.org\/10.1007\/s13679-022-00470-4.","journal-title":"Curr Obes Rep"},{"key":"1673_CR15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2337\/dc19-1057","volume":"43","author":"A Aminian","year":"2020","unstructured":"Aminian A, Vidal J, Salminen P, Still CD, Nor Hanipah Z, Sharma G, et al. Late relapse of diabetes after bariatric surgery: not rare, but not a failure. Diabetes Care. 2020;43:534\u201340. https:\/\/doi.org\/10.2337\/dc19-1057.","journal-title":"Diabetes Care"},{"key":"1673_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2016.64","volume":"8","author":"S Soleyman-Jahi","year":"2017","unstructured":"Soleyman-Jahi S, Abdirad A, Fallah AA, Ghasemi S, Sadeghi F, Heidari R, et al. Prognostic significance of preoperative and postoperative plasma levels of ghrelin in gastric cancer: 3-year survival study. Clin Transl Gastroenterol. 2017;8:e209. https:\/\/doi.org\/10.1038\/ctg.2016.64.","journal-title":"Clin Transl Gastroenterol"},{"key":"1673_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1210\/jcem-54-5-909","volume":"54","author":"J Takemura","year":"1982","unstructured":"Takemura J, Seino Y, Yamamura T, Tsuda K, Seino S, Itoh N, et al. The role of endogenous gastric inhibitory polypeptide in the enteroinsular axis. J Clin Endocrinol Metab. 1982;54:909\u201313. https:\/\/doi.org\/10.1210\/jcem-54-5-909.","journal-title":"J Clin Endocrinol Metab"},{"key":"1673_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jamcollsurg.2021.03.019","volume":"232","author":"Y Kwon","year":"2021","unstructured":"Kwon Y, Kwon JW, Kim D, Ha J, Park SH, Hwang J, et al. Predictors of remission and relapse of diabetes after conventional gastrectomy for gastric cancer: nationwide population-based cohort study. J Am Coll Surg. 2021;232:973-81.e2. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2021.03.019.","journal-title":"J Am Coll Surg"},{"key":"1673_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.soard.2015.11.024","volume":"12","author":"TW Ho","year":"2016","unstructured":"Ho TW, Wu JM, Yang CY, Lai HS, Lai F, Tien YW. Total gastrectomy improves glucose metabolism on gastric cancer patients: a nationwide population-based study. Surg Obes Relat Dis. 2016;12:635\u201341. https:\/\/doi.org\/10.1016\/j.soard.2015.11.024.","journal-title":"Surg Obes Relat Dis"},{"key":"1673_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.soard.2013.09.013","volume":"10","author":"Y Kwon","year":"2014","unstructured":"Kwon Y, Abdemur A, Lo Menzo E, Park S, Szomstein S, Rosenthal RJ. The foregut theory as a possible mechanism of action for the remission of type 2 diabetes in low body mass index patients undergoing subtotal gastrectomy for gastric cancer. Surg Obes Relat Dis. 2014;10:235\u201342. https:\/\/doi.org\/10.1016\/j.soard.2013.09.013.","journal-title":"Surg Obes Relat Dis"},{"key":"1673_CR21","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s10620-013-2965-6","volume":"59","author":"ZW Wei","year":"2014","unstructured":"Wei ZW, Li JL, Wu Y, Xia GK, Schwarz RE, He YL, et al. Impact of pre-existing type-2 diabetes on patient outcomes after radical resection for gastric cancer: a retrospective cohort study. Dig Dis Sci. 2014;59:1017\u201324. https:\/\/doi.org\/10.1007\/s10620-013-2965-6.","journal-title":"Dig Dis Sci"},{"key":"1673_CR22","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/jcsm.13206","volume":"14","author":"Y Kwon","year":"2023","unstructured":"Kwon Y, Ha J, Kim D, Hwang J, Park SH, Kwon JW, et al. The association between weight change after gastric cancer surgery and type 2 diabetes risk: a nationwide cohort study. J Cachexia Sarcopenia Muscle. 2023;14:826\u201334. https:\/\/doi.org\/10.1002\/jcsm.13206.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1673_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.102062","volume":"8","author":"N Silvestris","year":"2023","unstructured":"Silvestris N, Franchina T, Gallo M, Argentiero A, Avogaro A, Cirino G, et al. Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper. ESMO Open. 2023;8:102062. https:\/\/doi.org\/10.1016\/j.esmoop.2023.102062.","journal-title":"ESMO Open"},{"key":"1673_CR24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.soard.2020.03.003","volume":"16","author":"A Cho","year":"2020","unstructured":"Cho A, Kwon IG, Kim S, Noh SH, Ku CR. Altered systematic glucose utilization after gastrectomy: correlation with weight loss. Surg Obes Relat Dis. 2020;16:900\u20137. https:\/\/doi.org\/10.1016\/j.soard.2020.03.003.","journal-title":"Surg Obes Relat Dis"},{"key":"1673_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2337\/db16-1000","volume":"66","author":"CR Ku","year":"2017","unstructured":"Ku CR, Lee N, Hong JW, Kwon IG, Hyung WJ, Noh SH, et al. Intestinal glycolysis visualized by FDG PET\/CT correlates with glucose decrement after gastrectomy. Diabetes. 2017;66:385\u201391. https:\/\/doi.org\/10.2337\/db16-1000.","journal-title":"Diabetes"},{"issue":"2","key":"1673_CR26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.21147\/j.issn.1000-9604.2020.02.12","volume":"32","author":"WJ Kim","year":"2020","unstructured":"Kim WJ, Kwon Y, Lee CM, Lim SH, Li Y, Wang J, et al. Oncometabolic surgery: emergence and legitimacy for investigation. Chin J Cancer Res. 2020;32(2):252\u201362. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2020.02.12.","journal-title":"Chin J Cancer Res"},{"key":"1673_CR27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/01.sla.0000134632.08789.df","volume":"240","author":"A Patriti","year":"2004","unstructured":"Patriti A, Facchiano E, Donini A. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;240:388\u201391. https:\/\/doi.org\/10.1097\/01.sla.0000134632.08789.df.","journal-title":"Ann Surg"},{"key":"1673_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/01.sla.0000224726.61448.1b","volume":"244","author":"F Rubino","year":"2006","unstructured":"Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741\u20139. https:\/\/doi.org\/10.1097\/01.sla.0000224726.61448.1b.","journal-title":"Ann Surg"},{"key":"1673_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.soard.2007.02.003","volume":"3","author":"DE Cummings","year":"2007","unstructured":"Cummings DE, Overduin J, Foster-Schubert KE, Carlson MJ. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis. 2007;3:109.","journal-title":"Surg Obes Relat Dis"},{"key":"1673_CR30","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s11695-023-06631-1","volume":"33","author":"MA Salman","year":"2023","unstructured":"Salman MA, Abelsalam A, Nashed GA, Yacoub M, Abdalla A. Long biliopancreatic limb Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a randomized controlled study. Obes Surg. 2023;33:1966\u201373. https:\/\/doi.org\/10.1007\/s11695-023-06631-1.","journal-title":"Obes Surg"},{"key":"1673_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3748\/wjg.v18.i1.49","volume":"18","author":"JW Kim","year":"2012","unstructured":"Kim JW, Cheong JH, Hyung WJ, Choi SH, Noh SH. Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol. 2012;18:49\u201354. https:\/\/doi.org\/10.3748\/wjg.v18.i1.49.","journal-title":"World J Gastroenterol"},{"key":"1673_CR32","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1210\/jc.2004-0872","volume":"89","author":"TY Jeon","year":"2004","unstructured":"Jeon TY, Lee S, Kim HH, Kim YJ, Son HC, Kim DH, et al. Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab. 2004;89:5392\u20136. https:\/\/doi.org\/10.1210\/jc.2004-0872.","journal-title":"J Clin Endocrinol Metab"},{"key":"1673_CR33","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1007\/s11695-023-06857-z","volume":"33","author":"D Kehagias","year":"2023","unstructured":"Kehagias D, Lampropoulos C, Georgopoulos N, Habeos I, Kalavrizioti D, Vamvakas SS, et al. Diabetes remission after LRYGBP with and without fundus resection: a randomized clinical trial. Obes Surg. 2023;33:3373\u201382. https:\/\/doi.org\/10.1007\/s11695-023-06857-z.","journal-title":"Obes Surg"},{"key":"1673_CR34","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1007\/s13300-020-00934-7","volume":"11","author":"D Peng","year":"2020","unstructured":"Peng D, Cheng YX, Zhang W. Does Roux-en-Y construction really bring benefit of type 2 diabetes mellitus remission after gastrectomy in patients with gastric cancer? A systematic review and meta-analysis. Diabetes Ther. 2020;11:2863\u201372. https:\/\/doi.org\/10.1007\/s13300-020-00934-7.","journal-title":"Diabetes Ther"},{"key":"1673_CR35","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1210\/jc.2004-0699","volume":"90","author":"K Maedler","year":"2005","unstructured":"Maedler K, Carr RD, Bosco D, Zuellig RA, Berney T, Donath MY. Sulfonylurea induced beta-cell apoptosis in cultured human islets. J Clin Endocrinol Metab. 2005;90:501\u20136. https:\/\/doi.org\/10.1210\/jc.2004-0699.","journal-title":"J Clin Endocrinol Metab"},{"key":"1673_CR36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1089\/dia.2012.0144","volume":"14","author":"MS Shin","year":"2012","unstructured":"Shin MS, Yu JH, Jung CH, Hwang JY, Lee WJ, Kim MS, et al. The duration of sulfonylurea treatment is associated with \u03b2-cell dysfunction in patients with type 2 diabetes mellitus. Diabetes Technol Ther. 2012;14:1033\u201342. https:\/\/doi.org\/10.1089\/dia.2012.0144.","journal-title":"Diabetes Technol Ther"},{"key":"1673_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/dia.2006.8.375","volume":"8","author":"A Pf\u00fctzner","year":"2006","unstructured":"Pf\u00fctzner A, Lorra B, Abdollahnia MR, Kann PH, Mathieu D, Pehnert C, et al. The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus. Diabetes Technol Ther. 2006;8:375\u201384. https:\/\/doi.org\/10.1089\/dia.2006.8.375.","journal-title":"Diabetes Technol Ther"},{"key":"1673_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2023.101453","volume":"49","author":"AJ Scheen","year":"2023","unstructured":"Scheen AJ. Use of SGLT2 inhibitors after bariatric\/metabolic surgery: Risk\/benefit balance. Diabetes Metab. 2023;49:101453. https:\/\/doi.org\/10.1016\/j.diabet.2023.101453.","journal-title":"Diabetes Metab"},{"key":"1673_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.xkme.2019.12.006","volume":"2","author":"KM Wang","year":"2020","unstructured":"Wang KM, Isom RT. SGLT2 inhibitor-induced euglycemic diabetic ketoacidosis: a case report. Kidney Med. 2020;2:218\u201321. https:\/\/doi.org\/10.1016\/j.xkme.2019.12.006.","journal-title":"Kidney Med"},{"key":"1673_CR40","doi-asserted-by":"publisher","first-page":"14379","DOI":"10.1074\/jbc.REV120.008387","volume":"295","author":"RJ Perry","year":"2020","unstructured":"Perry RJ, Shulman GI. Sodium-glucose cotransporter-2 inhibitors: understanding the mechanisms for therapeutic promise and persisting risks. J Biol Chem. 2020;295:14379\u201390. https:\/\/doi.org\/10.1074\/jbc.REV120.008387.","journal-title":"J Biol Chem"},{"key":"1673_CR41","unstructured":"U.S. Food and Drug Administration. FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections: U.S. Food and Drug Administration; 2015 [updated 2022 Mar 16; cited 2024 Nov 5]. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-revises-labels-sglt2-inhibitors-diabetes-include-warnings-about-too-much-acid-blood-and-serious."},{"key":"1673_CR42","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/dom.12848","volume":"19","author":"D Yabe","year":"2017","unstructured":"Yabe D, Iwasaki M, Kuwata H, Haraguchi T, Hamamoto Y, Kurose T, et al. Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study. Diabetes Obes Metab. 2017;19:739\u201343. https:\/\/doi.org\/10.1111\/dom.12848.","journal-title":"Diabetes Obes Metab"},{"key":"1673_CR43","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.soard.2019.01.003","volume":"15","author":"M Gagner","year":"2019","unstructured":"Gagner M. Patient preferences or surgeon-enforced preferences, when deciding between Roux-en-Y gastric bypass versus sleeve gastrectomy. Surg Obes Relat Dis. 2019;15:312\u20133. https:\/\/doi.org\/10.1016\/j.soard.2019.01.003.","journal-title":"Surg Obes Relat Dis"},{"key":"1673_CR44","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00268-013-2291-3","volume":"38","author":"KC Wang","year":"2014","unstructured":"Wang KC, Huang KH, Lan YT, Fang WL, Lo SS, Li AF, et al. Outcome after curative surgery for gastric cancer patients with type 2 diabetes. World J Surg. 2014;38:431\u20138. https:\/\/doi.org\/10.1007\/s00268-013-2291-3.","journal-title":"World J Surg"},{"key":"1673_CR45","doi-asserted-by":"publisher","first-page":"23477","DOI":"10.1038\/s41598-024-72456-2","volume":"14","author":"M Pinho Costa","year":"2024","unstructured":"Pinho Costa M, Santos-Sousa H, Oliveira CR, Amorim-Cruz F, Bou\u00e7a R, Barbosa E, et al. The metabolic effects and effectiveness of the different reconstruction methods used in Gastric cancer surgery: a systematic review and meta-analysis. Sci Rep. 2024;14:23477. https:\/\/doi.org\/10.1038\/s41598-024-72456-2.","journal-title":"Sci Rep"},{"key":"1673_CR46","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4239\/wjd.v5.i3.328","volume":"5","author":"F Chabot","year":"2014","unstructured":"Chabot F, Caron A, Laplante M, St-Pierre DH. Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance. World J Diabetes. 2014;5:328\u201341. https:\/\/doi.org\/10.4239\/wjd.v5.i3.328.","journal-title":"World J Diabetes"},{"key":"1673_CR47","volume-title":"Gastric Cancer: Principles and Practice","author":"DE Stange","year":"2015","unstructured":"Stange DE, Weitz J. Methods of reconstruction\u2014BI, BII, Roux-en-Y, jejunal interposition, proximal gastrectomy and pouch reconstruction. In: Strong V, editor. Gastric Cancer: Principles and Practice. Cham: Springer; 2015."},{"key":"1673_CR48","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s11605-019-04255-4","volume":"24","author":"M Costa","year":"2020","unstructured":"Costa M, Trov\u00e3o Lima A, Morais T, Almeida RF, Nora M, Guimar\u00e3es M, et al. Does reconstruction type after gastric resection matters for type 2 diabetes improvement? J Gastrointest Surg. 2020;24:1269\u201377. https:\/\/doi.org\/10.1007\/s11605-019-04255-4.","journal-title":"J Gastrointest Surg"},{"key":"1673_CR49","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.soard.2015.01.001","volume":"11","author":"Y Kwon","year":"2015","unstructured":"Kwon Y, Jung Kim H, Lo Menzo E, Park S, Szomstein S, Rosenthal RJ. A systematic review and meta-analysis of the effect of Billroth reconstruction on type 2 diabetes: a new perspective on old surgical methods. Surg Obes Relat Dis. 2015;11:1386\u201395. https:\/\/doi.org\/10.1016\/j.soard.2015.01.001.","journal-title":"Surg Obes Relat Dis"},{"key":"1673_CR50","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5230\/jgc.2017.17.e34","volume":"17","author":"TH Lee","year":"2017","unstructured":"Lee TH, Lee CM, Park S, Jung DH, Jang YJ, Kim JH, et al. Long-term follow-up for type 2 diabetes mellitus after gastrectomy in non-morbidly obese patients with gastric cancer: the legitimacy of onco-metabolic surgery. J Gastric Cancer. 2017;17:283\u201394. https:\/\/doi.org\/10.5230\/jgc.2017.17.e34.","journal-title":"J Gastric Cancer"},{"key":"1673_CR51","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.asjsur.2019.03.018","volume":"43","author":"J-H Kim","year":"2020","unstructured":"Kim J-H, Huh Y-J, Park S, Park YS, Park DJ, Kwon J-W, et al. Multicenter results of long-limb bypass reconstruction after gastrectomy in patients with gastric cancer and type II diabetes. Asian J Surg. 2020;43:297\u2013303.","journal-title":"Asian J Surg"},{"key":"1673_CR52","doi-asserted-by":"publisher","first-page":"22451","DOI":"10.1038\/s41598-021-02001-y","volume":"11","author":"JY Park","year":"2021","unstructured":"Park JY, Kwon OK, Jeon JH, Choi YK, Park KB. Impact of the different biliopancreatic limb length on diabetes and incretin hormone secretion following distal gastrectomy in gastric cancer patients. Sci Rep. 2021;11:22451. https:\/\/doi.org\/10.1038\/s41598-021-02001-y.","journal-title":"Sci Rep"},{"issue":"1","key":"1673_CR53","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.2337\/dc22-0835","volume":"45","author":"Y Kwon","year":"2022","unstructured":"Kwon Y, Lee S, Kim D, A AL, Park SH, Lee CM, et al. Biliopancreatic limb length as a potential key factor in superior glycemic outcomes after roux-en-Y gastric bypass in patients with type 2 diabetes: a meta-analysis. Diabetes Care. 2022;45(1):3091\u2013100. https:\/\/doi.org\/10.2337\/dc22-0835.","journal-title":"Diabetes Care"},{"issue":"1","key":"1673_CR54","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1007\/s11695-024-07267-5","volume":"34","author":"FFE Bruinsma","year":"2024","unstructured":"Bruinsma FFE, Nienhuijs SW, Liem RSL, Greve JWM, Marang-van de Mheen PJ, Dutch Audit for Treatment of Obesity Research Group. The impact of longer biliopancreatic limb length on weight loss and comorbidity improvement at 5 years after primary roux-en-Y gastric bypass surgery: a population-based matched cohort study. Obes Surg. 2024;34(1):3236\u201345. https:\/\/doi.org\/10.1007\/s11695-024-07267-5.","journal-title":"Obes Surg"},{"key":"1673_CR55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ana.410170502","volume":"17","author":"R Malouf","year":"1985","unstructured":"Malouf R, Brust JC. Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol. 1985;17:421\u201330. https:\/\/doi.org\/10.1002\/ana.410170502.","journal-title":"Ann Neurol"},{"key":"1673_CR56","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1111\/dom.15234","volume":"25","author":"N McInnes","year":"2023","unstructured":"McInnes N, Hall S, Lochnan HA, Harris SB, Punthakee Z, Sigal RJ, et al. Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine\/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial. Diabetes Obes Metab. 2023;25:3347\u201355. https:\/\/doi.org\/10.1111\/dom.15234.","journal-title":"Diabetes Obes Metab"},{"key":"1673_CR57","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1097\/js9.0000000000001404","volume":"110","author":"Y Kwon","year":"2024","unstructured":"Kwon Y, Kim D, Kim S, Ha J, Hwang J, Park S, et al. Long-term cardiovascular risk reduction after gastric cancer surgery: a nationwide cohort study. Int J Surg. 2024;110:4266\u201374. https:\/\/doi.org\/10.1097\/js9.0000000000001404.","journal-title":"Int J Surg"},{"key":"1673_CR58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","volume":"10","author":"I Pernicova","year":"2014","unstructured":"Pernicova I, Korbonits M. Metformin\u2013mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol. 2014;10:143\u201356. https:\/\/doi.org\/10.1038\/nrendo.2013.256.","journal-title":"Nat Rev Endocrinol"},{"key":"1673_CR59","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.0416","volume":"155","author":"KM Reitz","year":"2020","unstructured":"Reitz KM, Marroquin OC, Zenati MS, Kennedy J, Korytkowski M, Tzeng E, et al. Association between preoperative Metformin exposure and postoperative outcomes in adults with type 2 diabetes. JAMA Surg. 2020;155:e200416. https:\/\/doi.org\/10.1001\/jamasurg.2020.0416.","journal-title":"JAMA Surg"},{"key":"1673_CR60","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.3390\/cancers12082013","volume":"12","author":"WS Chung","year":"2020","unstructured":"Chung WS, Le PH, Kuo CJ, Chen TH, Kuo CF, Chiou MJ, et al. Impact of metformin use on survival in patients with gastric cancer and diabetes mellitus following gastrectomy. Cancers. 2020;12:2013. https:\/\/doi.org\/10.3390\/cancers12082013.","journal-title":"Cancers"},{"key":"1673_CR61","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/biom11071022","volume":"11","author":"CH Tseng","year":"2021","unstructured":"Tseng CH. The relationship between diabetes mellitus and gastric cancer and the potential benefits of metformin: an extensive review of the literature. Biomolecules. 2021;11:1022. https:\/\/doi.org\/10.3390\/biom11071022.","journal-title":"Biomolecules"},{"key":"1673_CR62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","volume":"65","author":"R DeFronzo","year":"2016","unstructured":"DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism. 2016;65:20\u20139.","journal-title":"Metabolism"},{"key":"1673_CR63","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10120-024-01512-7","volume":"27","author":"OHI Chou","year":"2024","unstructured":"Chou OHI, Chauhan VK, Chung CTS, Lu L, Lee TTL, Ng ZMW, et al. Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study. Gastric Cancer. 2024;27:947\u201370. https:\/\/doi.org\/10.1007\/s10120-024-01512-7.","journal-title":"Gastric Cancer"},{"key":"1673_CR64","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s00125-017-4370-8","volume":"60","author":"H Tang","year":"2017","unstructured":"Tang H, Dai Q, Shi W, Zhai S, Song Y, Han J. SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Diabetologia. 2017;60:1862\u201372. https:\/\/doi.org\/10.1007\/s00125-017-4370-8.","journal-title":"Diabetologia"},{"key":"1673_CR65","doi-asserted-by":"publisher","first-page":"1057455","DOI":"10.3389\/fonc.2022.1057455","volume":"12","author":"D Jiang","year":"2022","unstructured":"Jiang D, Ma P. Canagliflozin, characterized as a HDAC6 inhibitor, inhibits gastric cancer metastasis. Front Oncol. 2022;12:1057455. https:\/\/doi.org\/10.3389\/fonc.2022.1057455.","journal-title":"Front Oncol"},{"key":"1673_CR66","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s40265-019-01148-3","volume":"79","author":"S Dhillon","year":"2019","unstructured":"Dhillon S. Dapagliflozin: a review in type 2 diabetes. Drugs. 2019;79:1135\u201346. https:\/\/doi.org\/10.1007\/s40265-019-01148-3.","journal-title":"Drugs"},{"key":"1673_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2014.09.018","volume":"224","author":"S De Jonghe","year":"2014","unstructured":"De Jonghe S, Proctor J, Vinken P, Feyen B, Wynant I, Marien D, et al. Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin. Chem Biol Interact. 2014;224:1\u201312. https:\/\/doi.org\/10.1016\/j.cbi.2014.09.018.","journal-title":"Chem Biol Interact"},{"key":"1673_CR68","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00535-010-0310-9","volume":"45","author":"T Okumura","year":"2010","unstructured":"Okumura T. Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs. J Gastroenterol. 2010;45:1097\u2013102. https:\/\/doi.org\/10.1007\/s00535-010-0310-9.","journal-title":"J Gastroenterol"},{"key":"1673_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3903","volume":"354","author":"P Korhonen","year":"2016","unstructured":"Korhonen P, Heintjes EM, Williams R, Hoti F, Christopher S, Majak M, et al. Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries. BMJ. 2016;354:i3903. https:\/\/doi.org\/10.1136\/bmj.i3903.","journal-title":"BMJ"},{"key":"1673_CR70","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/cam4.1354","volume":"7","author":"H Tang","year":"2018","unstructured":"Tang H, Shi W, Fu S, Wang T, Zhai S, Song Y, et al. Pioglitazone and bladder cancer risk: a systematic review and meta-analysis. Cancer Med. 2018;7:1070\u201380. https:\/\/doi.org\/10.1002\/cam4.1354.","journal-title":"Cancer Med"},{"key":"1673_CR71","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s11695-011-0580-1","volume":"22","author":"W Lee","year":"2012","unstructured":"Lee W, Ahn SH, Lee JH, Park DJ, Lee HJ, Kim HH, et al. Comparative study of diabetes mellitus resolution according to reconstruction type after gastrectomy in gastric cancer patients with diabetes mellitus. Obes Surg. 2012;22:1238\u201343. https:\/\/doi.org\/10.1007\/s11695-011-0580-1.","journal-title":"Obes Surg"},{"key":"1673_CR72","doi-asserted-by":"publisher","first-page":"9410","DOI":"10.3748\/wjg.v19.i48.9410","volume":"19","author":"JY An","year":"2013","unstructured":"An JY, Kim YM, Yun MA, Jeon BH, Noh SH. Improvement of type 2 diabetes mellitus after gastric cancer surgery: short-term outcome analysis after gastrectomy. World J Gastroenterol. 2013;19:9410\u20137. https:\/\/doi.org\/10.3748\/wjg.v19.i48.9410.","journal-title":"World J Gastroenterol"},{"key":"1673_CR73","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11695-014-1426-4","volume":"25","author":"Z Zhu","year":"2015","unstructured":"Zhu Z, Shan X, Cheng Y, Xu J, Fu H, Wang W, et al. Clinical course of diabetes after gastrectomy according to type of reconstruction in patients with concurrent gastric cancer and type 2 diabetes. Obes Surg. 2015;25:673\u20139. https:\/\/doi.org\/10.1007\/s11695-014-1426-4.","journal-title":"Obes Surg"},{"key":"1673_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188904","volume":"12","author":"YY Choi","year":"2017","unstructured":"Choi YY, Noh SH, An JY. A randomized controlled trial of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2 diabetes mellitus after distal gastrectomy in gastric cancer patients. PLoS ONE. 2017;12:e0188904. https:\/\/doi.org\/10.1371\/journal.pone.0188904.","journal-title":"PLoS ONE"},{"key":"1673_CR75","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.soard.2017.05.012","volume":"13","author":"MJ Park","year":"2017","unstructured":"Park MJ, Kim DH, Park BJ, Kim S, Park S, Rosenthal RJ. Impact of preoperative visceral fat proportion on type 2 diabetes in patients with low body mass index after gastrectomy. Surg Obes Relat Dis. 2017;13:1361\u20138. https:\/\/doi.org\/10.1016\/j.soard.2017.05.012.","journal-title":"Surg Obes Relat Dis"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01673-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-025-01673-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01673-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:02:52Z","timestamp":1790726572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-025-01673-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1673"],"URL":"https:\/\/doi.org\/10.1007\/s10120-025-01673-z","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}